共 50 条
- [31] Cardiac Dose and Survival Following Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E454 - E454
- [32] Defining Optimal Comorbidity Measures for Patients With Medically Inoperable Early-stage Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Body Radiation Therapy (SBRT) [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S172 - S172
- [33] A Phase II Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-risk Medically Inoperable Early-stage Non-small Cell Lung Cancer Reply [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (03): : 745 - 745
- [35] Stereotactic Body Radiation Therapy for Early Non-Small Cell Lung Cancer [J]. CONTROVERSIES IN TREATMENT OF LUNG CANCER, 2010, 42 : 94 - 114
- [37] Cardiac Radiation Dose Distribution and Cardiotoxicity in Early-Stage Non-small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E492 - E492
- [38] Impact of Cardiac Radiation Dosimetry on Overall Survival in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S92 - S92
- [39] Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers [J]. FRONTIERS IN ONCOLOGY, 2021, 11
- [40] Early-Stage Non-Small Cell Lung Cancer in Elderly Patients: Should Stereotactic Radiation Therapy Be the Standard of Care? [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05): : 1058 - 1059